(Q39384380)

English

Quality of life and pain relief during treatment with calcitriol and docetaxel in symptomatic metastatic androgen-independent prostate carcinoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Quality of life and pain relief during treatment with calcitriol and docetaxel in symptomatic metastatic androgen-independent prostate carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

quality of life

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

object named as

Tomasz M Beer

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

author name string

Kristine M Eilers

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Mark Garzotto

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Yi-Ching Hsieh

4

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Motomi Mori

5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

language of work or name

0 references

publication date

1 February 2004

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

100

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

758-763

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Assessment of cancer pain: a continuous challenge

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20024

7 January 2021

based on heuristic

inferred from DOI database lookup

Less pain does equal better quality of life following strontium-89 therapy for metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20024

7 January 2021

based on heuristic

inferred from DOI database lookup

Pain and health-related quality of life in a geographically defined population of men with prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20024

7 January 2021

based on heuristic

inferred from DOI database lookup

Rhenium-188 HEDP to treat painful bone metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20024

7 January 2021

based on heuristic

inferred from DOI database lookup

Feasibility of quantitative pain assessment in outpatient oncology practice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20024

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20024

7 January 2021

based on heuristic

inferred from DOI database lookup

Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer: results of the cancer and leukemia group B 9182 study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20024

7 January 2021

based on heuristic

inferred from DOI database lookup

Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20024

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of weekly docetaxel in symptomatic androgen-independent prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20024

7 January 2021

based on heuristic

inferred from DOI database lookup

Weekly high-dose calcitriol and docetaxel in advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20024

7 January 2021

based on heuristic

inferred from DOI database lookup

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20024

7 January 2021

based on heuristic

inferred from DOI database lookup

Psychometric properties and responsiveness of the EORTC quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20024

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of metastatic prostatic cancer with low-dose prednisone: evaluation of pain and quality of life as pragmatic indices of response

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20024

7 January 2021

based on heuristic

inferred from DOI database lookup

The McGill Pain Questionnaire: Major properties and scoring methods

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20024

7 January 2021

based on heuristic

inferred from DOI database lookup

Interpreting the significance of changes in health-related quality-of-life scores.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20024

7 January 2021

based on heuristic

inferred from DOI database lookup

Health-related quality of life in men with metastatic prostate cancer treated with prednisone alone or mitoxantrone and prednisone

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20024

7 January 2021

based on heuristic

inferred from DOI database lookup

Unbalanced repeated-measures models with structured covariance matrices.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20024

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of prednisone on prostate-specific antigen in patients with hormone-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20024

7 January 2021

based on heuristic

inferred from DOI database lookup

Antitumor activity of suramin in hormone-refractory prostate cancer controlling for hydrocortisone treatment and flutamide withdrawal as potentially confounding variables

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20024

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective evaluation of hydrocortisone and suramin in patients with androgen-independent prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20024

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate specific antigen levels and clinical response to low dose dexamethasone for hormone-refractory metastatic prostate carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20024

7 January 2021

based on heuristic

inferred from DOI database lookup

Corticosteroids significantly delay the onset of docetaxel-induced fluid retention: final results of a randomized study of the European Organization for Research and Treatment of Cancer Investigational Drug Branch for Breast Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20024

7 January 2021

based on heuristic

inferred from DOI database lookup

Dexamethasone does not significantly contribute to the response rate of docetaxel and estramustine in androgen independent prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20024

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic pain management in older people

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20024

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of docetaxel, estramustine, and low dose hydrocortisone on the quality of life of men with hormone refractory prostate cancer and their partners: a feasibility study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20024

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.20024

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39384380&oldid=2186343525"